©The Author(s) 2025.
World J Gastrointest Pathophysiol. Dec 22, 2025; 16(4): 111306
Published online Dec 22, 2025. doi: 10.4291/wjgp.v16.i4.111306
Published online Dec 22, 2025. doi: 10.4291/wjgp.v16.i4.111306
Table 2 Naranjo adverse drug reaction probability scale for the patient
| Question | Yes | No | Do not know | Score |
| Are there previous conclusive reports on this reaction? | + 1 | 0 | 0 | + 1 |
| Did the adverse event appear after the suspected drug was administered? | + 2 | - 1 | 0 | + 2 |
| Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered? | + 1 | 0 | 0 | + 1 |
| Did the adverse reaction reappear when the drug was readministered? | + 2 | - 1 | 0 | 0 |
| Are there alternative causes (other than the drug) that could on their own have caused the reaction? | - 1 | + 2 | 0 | + 2 |
| Did the reaction reappear when a placebo was given? | - 1 | + 1 | 0 | 0 |
| Was the drug detected in the blood (or other fluids) in concentrations known to be toxic? | + 1 | 0 | 0 | 0 |
| Was the reaction more severe when the dose was increased or less severe when the dose was decreased? | + 1 | 0 | 0 | 0 |
| Did the patient have a similar reaction to the same or similar drugs in any previous exposure? | + 1 | 0 | 0 | 0 |
| Was the adverse event confirmed by any objective evidence? | + 1 | 0 | 0 | + 1 |
| Total score | 7 | |||
- Citation: English K. Drug-induced liver injury from high-dose intravenous methylprednisolone: A rare but known adverse effect. World J Gastrointest Pathophysiol 2025; 16(4): 111306
- URL: https://www.wjgnet.com/2150-5330/full/v16/i4/111306.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v16.i4.111306